MSH2 and breast carcinoma: In the recent studies, polymorphism of hMSH2 may be associated with an elevated tumour risk in the Polish populations, regarding breast cancer [49], while there are still no data, which would be illustrating the significance of hMSH2 polymorphism for TNBC development in other populations.